NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/03/2025
Back to search
Official data from USPTO
PANAVANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/03/2025
Trademark type
Word
Nice classes
44
Filing date
09/22/2021
Registration date
06/03/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2025
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-12-00
First use in commerce
2021-12-00
Drawing code
4
Owner type
03
Owner location
BERYWN, PA, US
Examiner
MARTIN, CHRISTINE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PANAVANCE THERAPEUTICS INC.
Panavant Therapeutics Inc.
Representatives
Roger H. Bora THOMPSON HINE LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing information in the field of preventionscreeningdiagnosis and treatment of oncological diseases and disorders
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/12/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/12/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/09/2025
IUAF
USE AMENDMENT FILED
05/08/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/08/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/01/2025
EX5G
SOU EXTENSION 5 GRANTED
03/31/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/31/2025
EXT5
SOU EXTENSION 5 FILED
12/16/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/30/2024
EX4G
SOU EXTENSION 4 GRANTED
05/29/2024
EXT4
SOU EXTENSION 4 FILED
05/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2023
EX3G
SOU EXTENSION 3 GRANTED
11/30/2023
EXT3
SOU EXTENSION 3 FILED
11/30/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/22/2023
EX2G
SOU EXTENSION 2 GRANTED
06/20/2023
EXT2
SOU EXTENSION 2 FILED
06/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/06/2022
EX1G
SOU EXTENSION 1 GRANTED
12/02/2022
EXT1
SOU EXTENSION 1 FILED
12/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
ALIE
ASSIGNED TO LIE
03/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/24/2022
DOCK
ASSIGNED TO EXAMINER
03/10/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2021
NWAP
NEW APPLICATION ENTERED
09/25/2021
Continuous trademark protection
Get notified about every new filing that threatens PANAVANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.